Medicine & Life Sciences

1. Myelodysplastic Syndromes 100%
2. Chelation Therapy 36%
3. Acute Myeloid Leukemia 35%
4. CD34 Antigens 34%
5. eculizumab 33%
6. Multiple Myeloma 32%
7. Bone Marrow 29%
8. Belgium 29%
9. Iron 27%
10. Lymphoma, Large B-Cell, Diffuse 27%
11. Protein-Tyrosine Kinases 21%
12. Postpartum Period 21%
13. Paroxysmal Hemoglobinuria 20%
14. Primary Myelofibrosis 19%
15. Lymphoma 19%
16. Leukemia 19%
17. Sagittal Sinus Thrombosis 18%
18. Extranodal NK-T-Cell Lymphoma 18%
19. Rituximab 17%
20. Hemoglobinuria 17%
21. Superior Sagittal Sinus 15%
22. Reed-Sternberg Cells 15%
23. Immunophenotyping 15%
24. Peripheral T-Cell Lymphoma 15%
25. Cytarabine 15%
26. Waldenstrom Macroglobulinemia 15%
27. Survival 14%
28. Peripheral Blood Stem Cell Transplantation 14%
29. Hemophagocytic Lymphohistiocytosis 14%
30. Epstein-Barr Virus Infections 14%
31. Myeloproliferative Disorders 14%
32. Group Processes 13%
33. Precursor Cell Lymphoblastic Leukemia-Lymphoma 12%
34. Allogeneic Cells 11%
35. Stem Cell Transplantation 11%
36. Antigens 11%
37. Refractory Anemia with Excess of Blasts 11%
38. Janus Kinase 2 11%
39. Human Herpesvirus 4 11%
40. Radiotherapy 10%
41. Natural Killer Cells 10%
42. Sunitinib 10%
43. T-Lymphocytes 9%
44. Therapeutics 9%
45. Imatinib Mesylate 9%
46. Thrombosis 8%
47. Rehabilitation 8%
48. Mutation 8%
49. Cross-Sectional Studies 7%